Inscrivez-vous 01 49 36 46 20
Date de publication : 20/11/2020
Date de péremption :
Type de procédure : Sans objet
Type de document : Avis de pré-information

Royaume-Uni-Londres: Services de laboratoire de recherche

2020/S 227-560552  (Source TED)
V  E  R  S  I  O  N      F  R  A  N  C  A  I  S  E
TX: 20/11/2020 S227 Royaume-Uni-Londres: Services de laboratoire de recherche 2020/S 227-560552 Avis de préinformation
Le présent avis est un avis de préinformation uniquement Services
Section I: Pouvoir adjudicateur
I.1) Nom et adresses Nom officiel: Department of Health and Social Care Adresse postale: 39 Victoria Street Ville: London Code NUTS: UKI32 Westminster Code postal: SW1H 0EU Pays: Royaume-Uni Courriel: Adresse(s) internet:
Adresse principale: Adresse du profil d'acheteur:
I.3) Communication Adresse à laquelle des informations complémentaires peuvent être obtenues: le ou les point(s) de contact susmentionné(s) La communication électronique requiert l'utilisation d'outils et de dispositifs qui ne sont pas généralement disponibles. Un accès direct non restreint et complet à ces outils et dispositifs est possible gratuitement à l'adresse:
I.4) Type de pouvoir adjudicateur Ministère ou toute autre autorité nationale ou fédérale, y compris leurs subdivisions régionales ou locales
I.5) Activité principale Santé
Section II: Objet
II.1) Étendue du marché
II.1.1) Intitulé:
NHS Test and Trace: Mass Spectrometry Pilot P2 - P3
II.1.2) Code CPV principal 73111000 Services de laboratoire de recherche
II.1.3) Type de marché Services
II.1.4) Description succincte:
Testing for Coronavirus is a crucial part of the government's response to the pandemic. The national Covid-19 testing strategy has pivoted toward mass population testing. To achieve this ambition a concerted effort to mobilise a range of viable testing solutions is needed. Following a feasibility study ('P1'), the initiation of targeted pilot studies are proposed as the next step in mobilising mass spectrometry for Covid-19 testing. This PIN is for a market engagement event to understand the capacity and capability of the market for goods and services that DHSC envisions may be required under the next phases of the pilot (P2 and P3).
II.1.5) Valeur totale estimée Valeur hors TVA: 2 500 000.00 GBP
II.1.6) Information sur les lots Ce marché est divisé en lots: non
II.2) Description
II.2.2) Code(s) CPV additionnel(s) 73000000 Services de recherche et développement et services de conseil connexes 73111000 Services de laboratoire de recherche 73111000 Services de laboratoire de recherche 33140000 Consommables médicaux 33696500 Réactifs de laboratoire 72300000 Services de commutation de données 80420000 Services d'enseignement par voie électronique 33100000 Équipements médicaux
II.2.3) Lieu d'exécution Code NUTS: UK UNITED KINGDOM
II.2.4) Description des prestations:
The intended objectives of the programme are to support the Covid-19 testing strategy by: assessing and verifying that the published methods of mass spectrometry can provide a confirmatory diagnosis of patients' infection status; validating that mass spectrometry can act as a diagnostic screen for patient samples from NHS test centres and validation of workflow to certain specifications (i.e. turnaround time); scaling methodology for mass testing with industry to support the development of end-to-end efficiencies (i.e. sample preparation through to data aggregation); rolling out mass spectrometry as a diagnostic tool for Covid-19 nationally across multiple regional centres. The Department of Health and Social Care (DHSC) intends to divide the procurement activity for this opportunity into contracting for the following phases: P2: clinical validation, maximum duration of 4 weeks; P3(a): scale validation, maximum duration of 12 weeks; P3(b): NHS scale-up, maximum duration of 4 weeks; P3(c): industrial scale up, duration to be confirmed The estimated value for P2 is GBP
   2. 5 million. DHSC intends to divide the procurement into lots based on the nature of goods or services to be provided. The scope of these individual lots is yet to be determined, but is intended to cover the following areas: laboratories and associated equipment for clinical validation; laboratories and associated equipment to build capacity; reagents; consumables; data transfer services (P3 only); eLearning for laboratory technicians. The Department wishes to engage with the market in order to share information about potential upcoming opportunities and understand the capacity and capability of the market. Interested parties are invited to join a virtual market engagement event on 26 November 2020 where more details will be provided. When responding to this notice, please provide contact information for the representatives that you are nominating to attend the event, (maximum three per organisation). We request that organisations determine who would be best placed to attend. Responses should be sent to by 12 p.m. UK time, 25 November 2020. Please email using the subject line 'Response to PIN - Market Engagement Event'.
II.2.14) Informations complémentaires Next steps and key dates: (25 November 2020): deadline to register for the market engagement event. The agenda and protocols will be provided to all participants prior to the event. The event will be recorded for transparency and audit purposes. (26 November 20): market engagement event held. For further information or any enquiries on the above please contact
II.3) Date prévue pour le lancement de la procédure de passation:
Section IV: Procédure
IV.1) Description
IV.1.8) Information concernant l'accord sur les marchés publics (AMP)
Le marché est couvert par l'accord sur les marchés publics: non
Section VI: Renseignements complémentaires
VI.3) Informations complémentaires:
This notice is for information only, and the Department reserves the right to supplement and vary the conduct of the prior engagement process. Where this occurs, the Department will act transparently and treat all interested parties who have expressed an interest equally. The Department reserves the right to discontinue the proposed tendering process and not award any contracts pursuant to this notice. The information contained in this notice, including information relating to the nature and scope of the Department's requirements, the service classification of this requirement or the list of CPV codes, is only indicative of the Department's current thinking and is neither exhaustive nor binding. The Department reserves the right at its absolute discretion to amend it at the time of issue of any further notices or at any other time. The publication of this notice in no way obliges the Department to commence with any competitive tender process. The Department is not and shall not be liable for any costs incurred by those expressing any interest in participating in the market engagement exercise advertised in this notice.
VI.5) Date d'envoi du présent avis:
C L A S S E    C P V
33100000 - Équipements médicaux 
33140000 - Consommables médicaux 
33696500 - Réactifs de laboratoire 
72300000 - Services de commutation de données 
73000000 - Services de recherche et développement et services de conseil connexes 
73111000 - Services de laboratoire de recherche 
80420000 - Services d'enseignement par voie électronique